Both the protein used and the conjugation method are factors which may be relevant for targeting infection w ith n lIn-labelled proteins. In this study, human immunoglobulin G (IgG), conjugated to either DTPA or LiLo, and LiLo conjugated hum an immunoglobulin M (IgM) were evaluated. In rats with Staphylococcus aureus calf muscle infection, biodistribution was determined 6, 24 and 48 h after the injection of l1lIn-DTPA-IgG, ln In-LiLo-IgG or ln In-LiLo-IgM, Absolute abscess uptake of n lIn-LiLo-IgG w as significantly higher than that of u1In-DTPA-IgG (P < 0.05). Since blood clearance of n lIn-LiLo-IgG w as initially significantly slower (P < 0.01), the higher abscess uptake did not result in higher abscess-tobackground ratios. m In-LiLo-IgG accumulated to a greater extent in the liver (P < 0.001). m In-DTPAIgG show ed higher uptake in the kidneys and bone marrow (P < 0.001 and P < 0.01, respectively). Although decreasing over time, m In-LiLo-IgM showed reasonable abscess uptake and rapid blood clear ance, resulting in higher abscess-to-background ratios compared with m In-LiLo-IgG (P < 0.01). H ow ever, liver and spleen uptake w ere three-to four-fold higher than that of rnIn-LiLo-lgG (P < 0.001). Compared w ith DTPA-conjugation, chelation with LiLo has a minor influence on abscess targeting of m In-labelled IgG. However, differences in blood clearance and organ uptake do occur. n lIn-LiLo-IgM shows high relative accumulation in abscesses as w ell as high liver and spleen uptake. n tIn-LiLoIgM appears promising for imaging infection outside the trunk region.
Introduction
A number of studies have demonstrated the utility Of m In-labelled non-specific polyclonal human immuno globulin G (n iIn-IgG) scintigraphy for the detection of various types of focal infection in humans [1, 2] . In a clinically used formulation, the protein is conjugated with the bifunctional chelating agent diethylenetriamine-pentaacetic (DTPA) cyclic anhydride for labelling with m In. However, the chelator may play an important role in the distribution of the radiolabel in various tis sues [3] . Release of m In from the conjugates produces a continuous leakage of radionuclide into the blood, resulting in transport through transferrin to the liver and other organs of the mononuclear phagocytic system [4] , It has been suggested that l, 3- [3] , In the first part of Hie study, IgG conjugated to either DTPA or LiLo and subse quently labelled with 111 In was studied in a rat model of infection.
Not only may the ligand be relevant for biodislrilnition, but the protein may also play an important role [5] . As reported previously, proteins smaller than IgG (such as human serum albumin) accumulate in a similar fash ion to IgG in experimental infection. However, the back ground activity is higher, due to the higher influx into the non-target tissues [5, 6] , resulting in lower abscessto-background ratios of albumin compared with IgG [5] , In the second part of the study, IgM (molecular weight 900 kDa, which is five times larger than IgG) was radiolabelled with rnIn after LiLo conjugation and compared with m In-LiLo-IgG.
Materials and methods

Radiopharmaceuticals
IUIn-D T P A -lgG .
The bifunctional chelating agent DTPA bicyclic anhydride was conjugated to IgG (Sandoglobulin, Sandoz AG, Nürnberg, Germany) as described pre viously [7] . Conjugation of DTPA to IgG resulted in two to three DTPA ligands per protein molecule.
m In-LiLo-IgG and m In-LiLo-IgM . As described earlier, the bifunctional chelating agent LiLo was conjugated to IgG (Sandoglobulin, Sandoz AG, Nürnberg, Germany) and to the human monoclonal IgM antibody 16.88, direc ted against an intracellular epitope in adenocarcinoma cells (Perimmune Inc./Akzo Nobel, Rockville, MD, USA) [3] . Conjugation of LiLo to the proteins resulted in three to four LiLo ligands per protein molecule.
R adiolabelling and dosing
Aliquots of 0.5 mg of the conjugate were radiolabelled with in In (Indium chloride, Mallinckrodt Medical, Pette, The Netherlands) via citrate transchelation [5] , The radiochemical purity of the radiolabelled proteins was determined by instant thin-layer chromatography (ITLC) on Gelman ITLC-SG strips (Gelman Laboratories, Ann Arbor, MI) with 0.1 m citrate (pH = 5) as solvent. The labelling efficiency was always higher than 95%. A dose of 10 pg, labelled with 2 MBq m In, was injected intra venously.
A n im a ls and stu d y design
In young, male, randomly bred Wistar rats (weight 200-220 g), a calf muscle abscess was induced after ether anaesthesia with approximately 2 x l0 8 colony-forming units of Staphylococcus aureus in 0.1 ml of a 50:50 (v/v) suspension of autologous blood and normal saline. The animals were randomly divided into groups. Twentyfour hours after the inoculation of S. aureus in the mus cle, when swelling of the muscle was apparent, the respective radiopharmaceuticals were injected via the tail vein.
For tissue collection, the rats were killed with 30 mg phenobarbital injected intraperitoneally, followed by cer vical dislocation at 6, 24 and 48 h post-injection. Each protein was evaluated in five animals at each time point. Samples of bone marrow (taken from the right femur) and blood were collected. The infected left calf muscle, the right calf muscle, liver, spleen, kidneys, lung, duode num and the right femur were dissected and blotted dry. The activity in the tissues and samples was measured in a shielded well-type gammacounter. To correct for radio active decay and permit calculation of the uptake of the radiopharmaceuticals in each organ as a fraction of the injected dose, aliquots of the respective doses were coun ted simultaneously. The activity measured in the tissues and samples was expressed as a percentage of the injec ted dose per gram (% i.d. g~') and the excreted activity per animal as a percentage of the total dose adminis tered.
For calculation of background activity, we used a com bination of normal muscle activity and blood activity as described previously [5] , Since the blood volume of rats approximates to 60 ml per kg body weight (6%), 94% x the activity per gram in muscle plus 6%xthe activity per gram in blood was adopted as the value for background activity [8] . Abscess-to-background ratios were also calculated.
Statistical analysis
All mean values are given as % i.d. g _1 or ratios ± one standard error of the mean (s.e.m.). Statistical analysis was performed using one-way analysis of variance (ANOVA). The level of significance was set at P < 0.05.
Results
Comparison of m In-D TPA-lgG and m In-LiLo-IgG
As shown in Table 1 , conjugation of IgG with LiLo resul ted in a marginally higher amount of abscess uptake of rnIn-LiLo-IgG compared with in In-DTPA-IgG. Only at 48 h post-injection was a significant difference observed (P < 0.05). As shown in Fig. 1 , abscess-to-background ratios were similar at all time points. At 6 and 24 h post injection, blood levels of n iIn-LiLo-IgG were signifi cantly higher (P < 0.001-P < 0.01). As indicated in Table 2 , m In-LiLo-IgG showed relatively high liver uptake (P < 0.001), while the renal uptake of rnIn-DTPA-IgG was significantly higher (P < 0.001-P < 0.01). In spleen, lungs, bowel and initial bone marrow, the uptake of both agents was similar. At 48 h post-injection, bone marrow uptake of m In-DTPA-IgG was slightly, but significantly, higher (P < 0.05).
Comparison of m In-LiLo-lgG and m ln-LiLo-IgM
As shown in Table 1 , the uptake of m In-LiLo-IgM in the abscess was significantly lower compared with that of m In-LiLo-IgG (P < 0.001-P < 0.01). While the m InLiLo-IgG concentration in the abscess remained constant, significant washout of ulIn-LiLo-IgM was observed over time (P < 0.05). rnIn-LiLo-IgM cleared significantly faster from the blood than lu In-DTPA-IgG (P < 0.001). Due to this faster background clearance, the abscess-tobackground ratios of 111In-LiLo-IgM increased with time and were significantly higher than the ratios obtained with lu In-LiLo-IgG (P < 0.001). As indicated in Table 2 , n iIn-LiLo-IgM was in the main taken up in liver and spleen (P < 0.001), while renal, pulmonary and initial bowel uptake were significantly lower than those of Nuclear Medicine Communications (1996) 17 "P < 0.05; bP < 0.01; C P < 0.001. in In-LiLo-IgG (P < 0.001-P < 0.05). The bone marrow uptake of both radiopharmaceuticals was similar.
Discussion
The first aim of this study was to evaluate the possible advantage of using a more stable chelating agent than DTPA, such as LiLo [3] , for in In labelling of IgG. DTPAand LiLo-conjugated IgG showed similar abscess uptake and abscess-to-background ratios, indicating a more sta ble n iIn-labelled complex is not necessarily better suited for the detection of abscesses. It w ould appear that the Nuclear M edicine Communications (1996) 17 stability of m In-DTPA-IgG is sufficiently high to enable adequate abscess accumulation. It has been sh o w n that the dissociation and subsequent entrapment of rad io n u clide in the extracellular matrix is an im portant factor in m In uptake in experimental abscesses after the injection of m In-DTPA-IgG, while the protein or p ro te in frag ments are split off and washed out [9, 10] . Therefore, more stable in In chelation will not autom atically result in higher abscess uptake. The increased stability of the LiLo complex may be reflected in the slower b lo o d clear ance and lower bone marrow uptake. Uptake in organs was also affected: in In-LiLo-IgM accum ulated to a greater extent in liver, whereas u lIn-DTPA-IgG sh o w e d "P < 0.05; "P < 0.01; 'P < 0.001.
higher renal uptake. O ur data in rats w ith infection con cur w ith previous studies in tumour-bearing athymic mice in which four different inIn-chelate-antibody com plexes showed similar tumour uptake but a very differ ent distribution in organs [4] , Other studies have indicated that the most striking differences between radiometal-DTPA-antibody complexes and more stable chelates occur after the first 48 h post-injection [11, 12] . The second aim of the study was to evaluate the pos sible advantage of using a protein larger than IgG for the detection of infection. Striking differences were observed when we compared m In~LiLo-IgG w ith m In-LiLo-IgM. Although absolute abscess uptake of IgM was lower, abscess-to-background ratios were up to three times higher due to the very fast clearance from the back ground. As IgM is relatively large compared with IgG (900 vs 150 kDa), one might assume that penetration into an abscess would be more difficult. Although the ab solute uptake of IgM was as much as half that of IgG, it should be sufficiently high to make adequate imaging of foci possible. In contrast to the uptake of lu In in an abscess after in In-LiLo-IgG injection, which remains rel atively stable over time, ln In-LiLo-IgM uptake decreased in the abscess. This can be explained by the relatively fast clearance from blood and background compared with IgG, allowing niIn-LiLo-IgM washout from the abscess. These findings are similar to those in previous studies with m In-DTPA-IgA [5] . u lIn-DTPAIgA cleared even faster from the blood pool to liver, spleen and also kidneys than in In-LiLo-IgM. m In-DTPA-IgA was washed out of the abscess, while abscessto-background ratios increased w ith time [5] .
The rapid blood and background clearance of ln InLiLo-IgM was most probably due to fast, high uptake in liver and spleen. A liver uptake of 5% i.d. g _1 in a rat indicates total liver uptake of as much as 60%,i.d. Such high physiological liver uptake makes the agent unsuit able for imaging in the upper abdominal area. The much lower liver uptake of m In-DTPA-IgG is already known to obscure infectious lesions in the liver [13] . In areas outside the vicinity of the liver, liver uptake is irrelevant. Here, the high target-to-background ratios may prove advantageous, for example in the evaluation of infection of the peripheral locomotor system [1, 14] , Similar to the low background activity, the uptake of m In-LiLo-IgM in the kidneys and lungs is relatively low due to the fast and high liver uptake. Both in In-LiLo-IgG and lu InLiLo-IgM showed low bone marrow uptake and insig nificant bowel excretion.
In conclusion, chelation with LiLo has a minor influ ence on abscess targeting of lnIn-labelled IgG compared with DTPA conjugation, However, differences in blood clearance and organ uptake do occur. On the basis of experiments in rats, no clear-cut preference for either Nuclear M edicine Communications (1996) 17 method of chelation can be expressed. rnIn-LiLo-IgM shows high relative accumulation in abscesses, but also high liver and spleen uptake. The latter renders the 11'InLiLo-IgM preparation unsuitable for infection and inflammation imaging of the upper abdomen, but lu InLiLo-IgM holds promise for imaging infection outside the trunk region (e.g. the peripheral musculoskeletal system).
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